Back to search

Article

Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment

2024-03-28

Abstract excerpt

Avasimibe; a cholesterol-lowering drug with a proven safety in clinical trials, has recently been repositioned as an anticancer agent in various preclinical investigations. A study from our group reported that hypercholesterolemia promotes hepatocellular carcinoma (HCC) cell survival and hampers the anticancer effect of sorafenib, a kinase inhibitor. In the present study, we demonstrate that in HCC under hyperchol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee358793-b7f6-5e4b-b3b5-eadef7afa276
DOI
10.1101/2024.03.27.586757
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatmentDOI 10.1101/2024.03.27.586757
Select a neighboring publication to make it the new centre.